Institut De Recherches Internationales Servier (i.r.i.s.)

This early-phase study looks at how a single dose of the drug vorasidenib is handled by the body in people with severe liver impairment compared to those with normal liver function. About 20 participants will take one pill and be monitored for up to 77 days with blood tests and h…